U.S. Specialized REITs Stock News

NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet EVOLVE Trial Targets Type 2 Market As Shares Trade Below Targets

Insulet (NasdaqGS:PODD) has begun its pivotal EVOLVE study of a fully closed loop automated insulin delivery system for people with type 2 diabetes. The first participant has been enrolled, marking an important step in testing this technology beyond the company’s existing Omnipod 5 offering. The study focuses on expanding automated insulin delivery to a large and currently underserved segment of the diabetes population. For investors watching Insulet at a share price of $151.28, the EVOLVE...
NYSE:COMP
NYSE:COMPReal Estate

Compass (COMP) Turns TTM Profitable And Tests Bullish Margin Narratives

Q1 2026 results reset the earnings story Compass (COMP) opened 2026 with Q1 revenue of US$2.7 billion and basic EPS of US$0.03, alongside trailing twelve month EPS of US$0.02 on US$8.3 billion of revenue. The company has seen quarterly revenue move from US$1.36 billion in Q1 2025 through US$1.70 billion in Q4 2025 to US$2.7 billion in Q1 2026. Basic EPS has ranged from a loss of US$0.09 in Q1 2025 to a loss of US$0.07 in Q4 2025 and then to a profit of US$0.03 in the latest quarter, setting...
NYSE:DT
NYSE:DTSoftware

Assessing Dynatrace (DT) Valuation After Starboard Value’s Activist Push On Margins And Buybacks

Starboard Value’s new activist position in Dynatrace (DT) has turned the spotlight on the stock, with the investor urging margin expansion, faster share buybacks, and openness to options that could support shareholder value. See our latest analysis for Dynatrace. The stock has recently seen an 8% move on the Starboard announcement and a 2.69% gain on the latest trading day, yet the year to date share price return of 8.81% and 1 year total shareholder return of 18.44% both sit in negative...
NasdaqGM:WLFC
NasdaqGM:WLFCTrade Distributors

Is It Too Late To Consider Willis Lease Finance (WLFC) After Its Recent Share Price Surge?

If you are wondering whether Willis Lease Finance at around US$229 per share still offers value, you are not alone in asking what the current price really reflects. The stock has recently posted returns of 19.6% over 7 days, 30.2% over 30 days, 70.8% year to date and 72.3% over 1 year, with very large gains over 3 and 5 years. Recent headlines have focused on Willis Lease Finance within the capital goods and aircraft leasing space, highlighting how investors are paying closer attention to...
NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

A Look At Preformed Line Products (PLPC) Valuation After Q1 Earnings, Broker Downgrade And New Partnership

Q1 earnings, tax effects and new partnership shape investor focus Preformed Line Products (PLPC) drew attention after Q1 2026 results showed higher net sales but lower net income, along with a broker downgrade, a new FulcrumAir partnership, and a quarterly dividend announcement. See our latest analysis for Preformed Line Products. The stock has reacted strongly to the Q1 update, the FulcrumAir partnership and the dividend news, with a 1 month share price return of 25.33% and a year to date...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Properties DOC FFO Stability Tests Bullish Growth Narrative In FY 2025 Results

Healthpeak Properties FY 2025 earnings snapshot Healthpeak Properties (DOC) has reported new figures for FY 2025, with Q4 total revenue of US$719.4 million, basic EPS of US$0.16 and net income of US$113.8 million. These results contributed to a full year in which trailing twelve month revenue was about US$2.8 billion and EPS was US$0.10. Over recent quarters, the company’s revenue moved from US$697.9 million in Q4 FY 2024 to US$719.4 million in Q4 FY 2025, while quarterly EPS ranged from a...
NasdaqGS:EWTX
NasdaqGS:EWTXPharmaceuticals

Why Edgewise Therapeutics (EWTX) Is Up 21.5% After Positive Trial, FDA Updates And Equity Grants

Edgewise Therapeutics recently reported positive outcomes from drug trials and FDA-related developments, while also granting inducement stock options for 266,000 shares to nine new non-executive employees under its 2024 Inducement Equity Incentive Plan. These clinical updates, combined with a catalyst-rich pipeline and management’s decision to expand the team with equity-linked hires, highlight the company’s focus on executing its late- and mid-stage programs. We’ll now examine how the...
NYSE:UAMY
NYSE:UAMYMetals and Mining

Can UAMY’s Strong Balance Sheet Offset Antimony Production Uncertainty in Its Investment Story?

Recently, United States Antimony Corporation has faced bearish sentiment around its antimony production outlook, even as it maintains strong liquidity with solid cash and no meaningful debt but remains unprofitable. This combination of weak profitability, strong balance sheet, and uncertainty about future output has turned the company into a focal point for traders watching technical volatility and operational execution risk. We’ll now examine how concerns over United States Antimony’s...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

Talen Energy (TLN) Q1 Profit Of US$63 Million Tests Volatility Concerns

Talen Energy (TLN) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$1.38, alongside trailing 12 month revenue of US$3.4 billion and a small net loss of US$21 million that translates to basic EPS of US$0.46 in the red. Over recent quarters, the company has seen revenue range from US$454 million to US$1.1 billion and basic EPS swing between a loss of US$7.95 and a gain of US$4.53. This sets up a results season where investors will be focused on how consistently those higher...
NYSE:EVC
NYSE:EVCMedia

Entravision Communications (EVC) Returns To Quarterly Profit In Q1 2026 Challenging Bearish Narratives

Entravision Communications (EVC) has opened 2026 with Q1 revenue of US$197.0 million and basic EPS of US$0.13, alongside net income from ongoing operations of US$12.4 million. The company has seen revenue move from US$91.9 million in Q1 2025 and US$107.0 million in Q4 2024 to US$197.0 million in Q1 2026. EPS has shifted from losses of US$0.53 and US$0.62 in those respective quarters to a profit in the latest period, setting up a quarter where investors will be focused on how durable these...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai Holdings (BBAI) Q1 Loss Of US$56.8 Million Reinforces Bearish Profitability Narrative

BigBear.ai Holdings (BBAI) opened Q1 2026 with revenue of about US$34.4 million and a basic EPS loss of roughly US$0.12, setting the tone for another quarter where growth and profitability are pulling in different directions. Over recent periods, revenue has moved between US$27.3 million and US$43.8 million a quarter, while basic EPS has ranged from a small profit of about US$0.01 to a loss of roughly US$0.71, underscoring how volatile margins have been as the business scales. In that...
NYSE:TBI
NYSE:TBIProfessional Services

TrueBlue (TBI) Q4 Loss Of US$31.5 Million Tests Turnaround Narrative

TrueBlue FY 2025 earnings snapshot TrueBlue (TBI) has capped FY 2025 with fourth quarter revenue of US$418.2 million and a basic EPS loss of US$1.05. On a trailing twelve month view, revenue sits at about US$1.6 billion and EPS is a loss of US$1.61. Over recent quarters the company has reported revenue of US$382.4 million in Q3 2024 and US$418.2 million in Q4 2025, while quarterly EPS has ranged from a loss of US$0.26 in Q3 2024 to a loss of US$1.05 in Q4 2025. Margins remain under pressure,...
NasdaqGS:ANGI
NasdaqGS:ANGIInteractive Media and Services

Angi (ANGI) Margin Improvement Supports Bullish Profitability Narrative Despite Modest FY 2025 Revenue

Angi (ANGI) posts FY 2025 results with steady profitability and modest top line Angi (ANGI) closed FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.17, while trailing twelve month EPS reached US$0.96 on net income of US$43.8 million, setting a clear reference point for the year at a share price of US$7.41. Over the past six reported quarters, revenue has ranged from US$240.8 million to US$296.7 million, while quarterly basic EPS has moved between a loss of US$0.03...
NYSE:GNW
NYSE:GNWInsurance

Genworth Financial Q4 Loss On Steady Revenue Reinforces Concerns Over Margin Pressure

Genworth Financial (GNW) just closed FY 2025 with fourth quarter revenue of US$1.8 billion and a basic EPS loss of US$0.05, compared with revenue of US$1.8 billion and basic EPS of US$0.01 in the prior year’s fourth quarter. Over the past year, revenue across reported periods has sat in a tight band between US$1.8 billion and US$1.9 billion per quarter. Quarterly EPS has shifted from a small profit of US$0.01 in Q4 2024 to US$0.30 in Q3 2025 before slipping back into a modest loss in Q4 2025...
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

A Look At Remitly Global (RELY) Valuation As WhatsApp Expansion And Q1 2026 Earnings Near

Remitly Global (RELY) is back in focus after expanding its WhatsApp Send service, adding more supported countries and a new Request Money feature just ahead of its Q1 2026 results on May 6. See our latest analysis for Remitly Global. The WhatsApp expansion and anticipation around Q1 2026 have come alongside strong momentum, with an approximately 46% 1 month share price return, an 85% 3 month share price return, and a 12.6% 1 year total shareholder return, suggesting sentiment has improved...
NasdaqGS:UCTT
NasdaqGS:UCTTSemiconductor

A Look At Ultra Clean Holdings (UCTT) Valuation As AI Infrastructure Demand And Analyst Upgrades Draw Interest

Ultra Clean Holdings (UCTT) is back on investors’ radar after being lifted to a top Zacks Rank, with analysts raising earnings estimates in response to AI infrastructure demand and upgrades in wafer fab equipment spending. See our latest analysis for Ultra Clean Holdings. The stock’s momentum has been strong, with a 93.44% 90 day share price return and a 204.32% year to date share price return, contributing to a 332.35% 1 year total shareholder return as AI infrastructure interest and...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Narrower Losses And Reaffirmed Profitability Timeline

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...
NasdaqCM:ALTO
NasdaqCM:ALTOChemicals

Is Alto’s Tax-Aided Profit Turnaround Reshaping The Investment Case For Alto Ingredients (ALTO)?

Alto Ingredients, Inc. has already reported its Q1 2026 results, posting net income of US$4.0 million and Adjusted EBITDA of US$4.7 million, reflecting a return to profitability versus losses a year earlier. Management linked the turnaround to strong export sales, improved crush margins, new Section 45Z tax credit benefits, and an US$8.1 million unrealized derivative gain, while outlining plans to further monetize biogenic CO2 to lower the company’s carbon footprint. Next, we’ll examine how...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Q1 EPS Surge Tests Bullish Margin Narrative

Hecla Mining (HL) earnings snapshot Hecla Mining (HL) has put fresh numbers on the table for Q1 2026, with revenue of US$411.4 million, basic EPS of US$0.25 and net income from continuing operations of US$164.5 million, while also reporting earnings from discontinued operations of US$183.7 million. Over the past year, the company has seen revenue move from US$929.9 million on a trailing basis to US$1.57 billion and EPS shift from US$0.06 to US$0.69, alongside a very large year over year...
NYSE:WTTR
NYSE:WTTREnergy Services

Select Water Solutions (WTTR) Q4 Margin Strain Tests Bullish Earnings Growth Narrative

Select Water Solutions (WTTR) just wrapped up FY 2025 with Q4 revenue of US$346.5 million and a small net loss of US$0.3 million, equal to EPS of roughly US$0.00, while shares recently traded around US$17.25. Over the past few quarters, the company has seen revenue move between US$322.2 million and US$374.4 million, with EPS ranging from a loss of about US$0.02 in late 2024 to a high of roughly US$0.10 in Q2 2025. For investors, the mix of modest trailing net profit margin of 1.5% and...
NYSE:FG
NYSE:FGInsurance

Assessing F&G Annuities & Life (FG) Valuation As Recent Momentum Meets Mixed Earnings Expectations

Event context and recent stock move F&G Annuities & Life (FG) stock has drawn investor interest after a recent move, with the price at $29.42 and returns ranging from a 13% gain over the past month to a 15% decline over the past year. See our latest analysis for F&G Annuities & Life. The recent 3.81% 1-day share price return and 12.94% 30-day share price return contrast with a 14.67% decline in 1-year total shareholder return, so recent momentum is improving from a weaker long-term...
NYSE:XPRO
NYSE:XPROEnergy Services

Expro Group Holdings (XPRO) Swings To Q1 Loss Challenging Bullish Margin Improvement Narrative

Expro Group Holdings (NYSE:XPRO) opened 2026 with Q1 revenue of US$367.6 million and a small net loss of US$1.0 million, translating to EPS of roughly a US$0.01 loss, while the trailing twelve months show EPS of US$0.32 on revenue of about US$1.6 billion. Over recent quarters the company has seen revenue move from US$390.9 million in Q1 2025 to a peak of US$436.8 million in Q4 2024, before settling at US$367.6 million in the latest quarter. Quarterly EPS ranged from US$0.12 to US$0.20 profit...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Q4 Loss Of US$1.18b Tests Bullish Margin Improvement Narrative

Lucid Group (LCID) has just wrapped up FY 2025 with fourth quarter revenue of US$522.7 million, a basic EPS loss of US$3.62, and net income loss of US$1.18 billion. The trailing twelve month figures show revenue of US$1.35 billion and a basic EPS loss of US$11.81. The company’s revenue has moved from US$807.8 million on a trailing basis at the end of 2024 to US$1.35 billion by the end of 2025. EPS has remained deeply negative over the same stretch, setting up a results season in which...
NYSE:MA
NYSE:MADiversified Financial

Mastercard Tests Tokenized Treasuries As It Deepens Crypto Payment Rails

Mastercard (NYSE:MA) took part in the first near real time cross border settlement of a tokenized U.S. Treasury fund using blockchain, working with JPMorgan and Ripple. The pilot linked public blockchain infrastructure with traditional banking rails to support 24/7 settlement of tokenized Treasuries. Mastercard also agreed to acquire BVNK and expanded crypto partnerships with firms such as KuCoin and Rain to support stablecoin backed and digital asset payments. For you as an investor, this...